id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-5733	Di Cesare, Antonella; Rosi, Elia; Trovato, Emanuele; Pescitelli, Leonardo; Panduri, Salvatore; Manzo Margiotta, Flavia; Michelucci, Alessandra; Capalbo, Eugenio; Dragotto, Martina; Magnano, Michela ; Rossari, Susanna; Savarese, Imma; Buggiani, Gionata; Milanesi, Nicola; Lorenzoni, Elisa; Ricceri, Federica; Romanelli, Marco; Rubegni, Pietro; Pimpinelli, Nicola; Prignano, Francesca	Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study	2025	11	.pdf	application/pdf	7725	554	66	Furthermore, at week 52, NLR was significantly lower in SR patients (SR: 2.2; IQR: 1.78–2.53 versus LR: 2.48; IQR: 1.79–2.91; P=0.0495), despite the fact that ΔNLR was positively correlated to ΔPASI only in LR patients (P=0.022, r=0.37). Okada Y, Kajiyama K, Ishiguro C, Nonaka T, Komaki T, Kuga W, Komiyama N, Iguchi T, Horiuchi N, Uyama Y. Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in compari- son with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET®  in Japan.	cache/dpc-5733.pdf	txt/dpc-5733.txt